Notably, EC shows the highest frequency of PI3K pathway alterations (89%, including PIK3CA, PIK3R1, PTEN, AKT1/2/3, and MTOR) than any other cancers based on TCGA data (www.cbioportal.org [10], accessed on 29 May 2024). This evidence concerns the gene PIK3CB and cancer.